BASF (XTRA:BAS) On Strong Q2 Earnings And Portfolio Shift Looks Modestly Undervalued
BASF (XTRA:BAS) is back on watch after its second quarter 2026 earnings, which showed sharply higher sales and net income, alongside fresh progress on product approvals and portfolio reshaping across key business segments.
See our latest analysis for BASF.
The BASF share price has risen 12.55% year to date and the 1 year total shareholder return of 25.83% suggests momentum has been positive overall, even though the 90 day share price return is down 7.93% following recent earnings and deal headlines.
If BASF's recent earnings jump and product approvals have caught your attention, this can be a useful moment to broaden your opportunity set and check out 8 top copper producer stocks
The share price is still well below some valuation markers, even after a 1-year total return above 25% and a softer 90-day patch. Does that tilt the current BASF risk-reward balance towards buyers or caution when you look at valuation next?
Most Popular Narrative: 4.1% Undervalued
The most followed BASF narrative points to a fair value of about €52.55, slightly above the last close at €50.40. This sets up a balanced but constructive story around future cash flows and earnings quality.
Significant cost-savings programs (targeting €2.1 billion annual savings by end of 2026), alongside the completion of the major China Verbund investment (with project costs under budget and CapEx falling below depreciation from 2026), are expected to improve operating leverage and free cash flow, with cost competitiveness directly supporting net margins.
Want to see what sits behind that projected cash flow picture for BASF? The narrative leans heavily on margin rebuild, capital intensity peaking, and a different mix of earnings. It is important to understand which segments and assumptions carry the most weight. The full story links those moving parts into a single fair value number.
Result: Fair Value of €52.55 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, BASF still faces pressure from prolonged weak margins in base chemicals, as well as uncertainty around planned divestments and the potential Agricultural Solutions IPO, which could challenge this fair value story.
Find out about the key risks to this BASF narrative.
Another View on BASF’s Valuation
The popular BASF narrative leans heavily on analyst targets and earnings assumptions. Yet the SWS DCF model points to a very different picture, with a future cash flow value of about €113.52 against a current share price of €50.40, which is flagged as undervalued. That is a far wider gap than the 4.1% discount suggested by the consensus fair value. Which set of assumptions do you trust more?
Look into how the SWS DCF model arrives at its fair value.
Next Steps
With both cautious and optimistic signals around BASF in view, this is a good moment to look through the details yourself and decide how the balance of risks and rewards stacks up. To weigh both sides in one place, start with the 3 key rewards and 3 important warning signs
Looking for more BASF sized investment ideas?
If BASF is on your radar, now is the time to widen your field of vision and consider other stocks that could help inform your overall portfolio decisions.
- Explore potential mispricings by reviewing companies flagged in the 257 high quality undervalued stocks and identify which ones may warrant closer analysis before they attract broader attention.
- Focus on resilience by scanning the 302 resilient stocks with low risk scores for stocks that combine measured risk profiles with financial characteristics that may suit a steadier approach.
- Look for tomorrow's potential standouts early through the screener containing 525 high quality undiscovered gems and avoid relying only on the same well known large caps that many investors already hold.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com